UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota Journal article
Li, Chenwen, Zhao, Yang, Cheng, Juan, Guo, Jiawei, Zhang, Qixiong, Zhang, Xiangjun, Ren, Jiong, Wang, Fengchao, Huang, Jun, Hu, Houyuan, Wang, Ruibing, Zhang, Jianxiang. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota[J]. Advanced Science, 2019, 6(18).
Authors:  Li, Chenwen;  Zhao, Yang;  Cheng, Juan;  Guo, Jiawei;  Zhang, Qixiong; et al.
Favorite | TC[WOS]:136 TC[Scopus]:142  IF:14.3/16.3 | Submit date:2020/04/02
Colitis Targeting  Gut Microbiota  Nanotherapy  Proresolving Peptide  Reactive Oxygen Species  
Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent Journal article
Zhang, Xiangjun, Cheng, Qian, Li, Lanlan, Shangguan, Liqing, Li, Chenwen, Li, Shengke, Huang, Feihe, Zhang, Jianxiang, Wang, Ruibing. Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent[J]. THERANOSTICS, 2019, 9(11), 3107-3121.
Authors:  Zhang, Xiangjun;  Cheng, Qian;  Li, Lanlan;  Shangguan, Liqing;  Li, Chenwen; et al.
Favorite | TC[WOS]:38 TC[Scopus]:38  IF:12.4/12.0 | Submit date:2020/04/03
Antidote  Host-guest Chemistry  Neuromuscular Blocking Agent  Pillararene  Succinylcholine